Table 4. Sensitivity analyses for day 90 outcomes for both study sites combined.
ITTa N = 94 |
Confirmed only (PP) N = 56 |
Index only (PP) N = 60 |
||||
---|---|---|---|---|---|---|
n (%) | 95% CI | n (%) | 95% CI | n (%) | 95% CI | |
Cure | 35 (19.3) | 8.3–34.0 | 32 (37.1) | 14.4–63.8 | 37 (50.7) | 29.5–72.9 |
Good improvement | 18 (25.2) | 4.6–59.6 | 15 (39.1) | 9.3–75.8 | 15 (32.0) | 11.7–58.6 |
Partial improvement | 4 (6.2) | 0.6–21.4 | 0 | - | 0 | |
No improvement | 28 (35.0) | 8.9–72.2 | 0 | - | 0 | |
Relapse | 9 (14.3) | 1.9–40.5 | 9 (23.9) | 4.5–61.7 | 10 (17.4) | 4.5–40.7 |
CI: confidence interval, ITT: Intention to treat, PP: per protocol.
All proportions and 95% Confidence intervals shown here are adjusted by site.
aDummy patients were added for every outcome level for Boru Meda site to obtain estimates which could otherwise not be ontained due to sparse data.